Mahdi Garelnabi to Atherosclerosis
This is a "connection" page, showing publications Mahdi Garelnabi has written about Atherosclerosis.
Connection Strength
1.594
-
Punch E, Klein J, Diaba-Nuhoho P, Morawietz H, Garelnabi M. Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis. J Am Heart Assoc. 2022 02; 11(3):e023328.
Score: 0.836
-
Parthasarathy S, Litvinov D, Selvarajan K, Garelnabi M. Lipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability. Biochim Biophys Acta. 2008 May; 1781(5):221-31.
Score: 0.321
-
Wu T, Mazhar Z, Alsayrafi D, Garelnabi M. p-Cymene Modulate Oxidative Stress and Inflammation in Murine Macrophages: Potential Implication in Atherosclerosis. Cardiovasc Hematol Agents Med Chem. 2020; 18(2):151-157.
Score: 0.181
-
Litvinov D, Selvarajan K, Garelnabi M, Brophy L, Parthasarathy S. Anti-atherosclerotic actions of azelaic acid, an end product of linoleic acid peroxidation, in mice. Atherosclerosis. 2010 Apr; 209(2):449-54.
Score: 0.089
-
Raghavamenon A, Garelnabi M, Babu S, Aldrich A, Litvinov D, Parthasarathy S. Alpha-tocopherol is ineffective in preventing the decomposition of preformed lipid peroxides and may promote the accumulation of toxic aldehydes: a potential explanation for the failure of antioxidants to affect human atherosclerosis. Antioxid Redox Signal. 2009 Jun; 11(6):1237-48.
Score: 0.087
-
Garelnabi M, Selvarajan K, Litvinov D, Santanam N, Parthasarathy S. Dietary oxidized linoleic acid lowers triglycerides via APOA5/APOClll dependent mechanisms. Atherosclerosis. 2008 Aug; 199(2):304-9.
Score: 0.080